Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic
Veronika Bachanová, Michael R. Bishop, Parastoo B. Dahi, Bhagirathbhai Dholaria, Stephan A. Grupp, Brandon Hayes‐Lattin, Murali Janakiram, Richard T. Maziarz, Joseph P. McGuirk, Loretta J. Nastoupil, Olalekan O. Oluwole, Miguel‐Angel Perales, David L. Porter, Peter A. Riedell
Topics & Concepts
MedicineChimeric antigen receptorCoronavirus disease 2019 (COVID-19)Pandemic2019-20 coronavirus outbreakVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AntigenCell therapyReceptorImmunologyCellImmunotherapyInternal medicineImmune systemGeneticsOutbreakDiseaseBiologyInfectious disease (medical specialty)CAR-T cell therapy researchBiomedical Ethics and RegulationBiomedical and Engineering Education